Skip to Content Facebook Feature Image

FDA Approves Expanded Use of Miach Orthopaedics’ BEAR® Implant

News

FDA Approves Expanded Use of Miach Orthopaedics’ BEAR® Implant
News

News

FDA Approves Expanded Use of Miach Orthopaedics’ BEAR® Implant

2025-03-10 21:12 Last Updated At:21:30

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Mar 10, 2025--

Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears with the BEAR® Implant, has received U.S. Food & Drug Administration (FDA) 510(k) clearance to expand its indication to include children and adolescents of any age, as well as to treat partial ACL tears. The BEAR Implant previously received De Novo Approval in 2020 to treat skeletally mature patients at least 14 years of age with complete ACL tears.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250306000308/en/

The first disruptive technology in ACL tear treatment in more than 30 years, the BEAR Implant enables a torn ACL to heal and restores the natural function of the knee. It is a paradigm shift from the current standard of care, ACL reconstruction (ACLR), which replaces the ACL with a graft. To date, more than 5,000 patients have been treated with the BEAR Implant through clinical trial and commercial use.

“The way ACL tears are treated is reaching an inflection point, and the BEAR Implant is a significant driving force,” said Patrick McBrayer, president and CEO, Miach Orthopaedics. “Since the BEAR Implant was approved for commercial use four years ago, we have been proud to offer patients the opportunity to restore their native ACL anatomy without the need for more invasive reconstructive surgery. This FDA clearance is a significant step forward in our mission to change the standard of care in ACL surgery.”

More Natural ACL Surgery for Growing Kids

The approval is particularly significant for the thousands of young athletes who tear their ACLs each year. ACL reconstruction is often a much more complicated procedure in a growing child than it is in an adult because of their open growth plates (areas of cartilage located at the ends of the femur and tibia that play a critical role in bone growth). The BEAR Implant offers a more natural solution to ACL injuries and works with a child’s body as the musculoskeletal system continues to develop.

“Surgery to fix an ACL tear is different in children because we are concerned about causing damage to the growth plates, which can lead to issues such as limb length discrepancies and angular deformities,” said Dr. Sean Keyes, pediatric orthopedic surgeon at AdventHealth for Children. “The BEAR Implant allows us to restore the ACL to its original, natural state while preserving the growth plates. We believe this will improve the long-term health of the knee.”

ACL-Preserving Surgical Option for Partial Tears

While many partial tears are treated with physical therapy, bracing and activity modifications, surgery is often recommended if the tear is substantial or there is knee instability. In addition, a significant proportion of partial ACL tears progress to complete tears, especially in younger, active individuals, often leading to surgery.

“Our goal in treating patients with partial tears is to return them to a healthy, stable knee in the least invasive way possible,” said Dr. Nirav Amin, orthopedic surgeon at Premier Orthopaedic & Trauma Specialists in Southern California. “Until now, our options were conservative care with a watch and wait approach or ACL reconstruction, which completely removes their remaining healthy ACL tissue. The clearance of the BEAR Implant for partial tears enables us to offer patients an ACL-preserving procedure to stabilize their knees.”

Clinical evidence supporting the expanded indication included data from the BEAR III clinical trial and the Bridge Registry, for which participants have recently completed their two-year follow-up visits.

About The BEAR® Implant

The BEAR (Bridge-Enhanced ACL Restoration) Implant is a proprietary collagen-based implant used to facilitate healing of the torn ACL. The BEAR Implant is the first medical technology to demonstrate, with Level 1 clinical evidence, that it enables the body to heal its own torn ACL. Unlike reconstruction, which is the current standard of care, the BEAR Implant does not require a second surgical wound site to remove a healthy tendon from another part of the leg or the use of a donor tendon. The BEAR Implant acts as a bridge to help ends of the torn ACL heal together. The surgeon injects a small amount of the patient’s own blood into the implant and attaches it between the torn ends of the ACL in a minimally invasive procedure. The combination of the BEAR Implant and the patient’s blood enables the body to heal the torn ends of the ACL back together while maintaining the ACL’s original attachments to the femur and tibia. As the ACL heals, the BEAR Implant is resorbed by the body.

The BEAR Implant was first granted De Novo Approval from the U.S. Food and Drug Administration in December 2020. It is indicated for adults, adolescents and children with a complete or partial rupture of the ACL, as confirmed by MRI. Patients must have an ACL stump attached to the tibia to construct the repair. Children with open physes must have sufficient bone in the femoral and tibial epiphyses on either side of the intended tunnel locations to avoid disruption of the growth plates. Visit miachortho.com for complete product information, including Instructions for Use.

About Miach Orthopaedics, Inc.

Miach Orthopaedics, Inc., is a privately held company located in Westborough, Massachusetts, dedicated to developing surgical implants to facilitate connective tissue restoration. The company’s initial focus is the BEAR® Implant, which represents a paradigm shift in the treatment of ACL tears. For more information on Miach Orthopaedics and its products, visit www.miachortho.com and follow the company on Facebook, Instagram, TikTok and LinkedIn.

BEAR® Implant is a registered trademark of Miach Orthopaedics.

The BEAR Implant from Miach Orthopaedics is now cleared to treat torn ACLs in children and adolescents of any age, as well as partial tears. The implant is the first disruptive technology in ACL tear treatment in more than 30 years, enabling a torn ACL to heal and restoring the natural function of the knee. (Photo: Business Wire)

The BEAR Implant from Miach Orthopaedics is now cleared to treat torn ACLs in children and adolescents of any age, as well as partial tears. The implant is the first disruptive technology in ACL tear treatment in more than 30 years, enabling a torn ACL to heal and restoring the natural function of the knee. (Photo: Business Wire)

WASHINGTON (AP) — U.S. forces in the Caribbean Sea have seized another sanctioned oil tanker the Trump administration says has ties to Venezuela, part of a broader U.S. effort to take control of the South American country’s oil.

Homeland Security Secretary Kristi Noem wrote Thursday on social media, “Motor Tanker Veronica had previously passed through Venezuelan waters, and was operating in defiance of President Trump’s established quarantine of sanctioned vessels in the Caribbean.”

A social media post from U.S. Southern Command on the capture said that Marines and sailors launched from the aircraft carrier USS Gerald R. Ford to make the capture while Noem’s post noted that, like in previous raids, a U.S. Coast Guard tactical team conducted the boarding and seizure.

Noem posted a brief video that appeared to show part of the ship’s capture. The black-and-white footage showed helicopters hovering over the deck of a merchant vessel while armed troops dropped down on the deck by rope.

The Veronica is the sixth tanker that has been seized by U.S. forces as part of the effort by President Donald Trump’s administration to control the production, refining and global distribution of Venezuela’s oil products, and the fourth since the U.S. ouster of Venezuela President Nicolás Maduro in a surprise nighttime raid almost two weeks ago.

Noem, in her social media post, said that the raid was carried out with “close coordination with our colleagues” in the military as well as the State and Justice departments.

“Our heroic Coast Guard men and women once again ensured a flawlessly executed operation, in accordance with international law,” Noem added.

As with prior posts, Noem and the military framed the seizure as part of an effort to enforce the law. Noem argued that the multiple captures show that “there is no outrunning or escaping American justice.”

However, other officials in Trump's Republican administration have made clear they see it as a way to generate cash as they seek to rebuild Venezuela’s battered oil industry and restore its economy.

Last week, Trump met with executives from oil companies to discuss his goal of investing $100 billion in Venezuela to repair and upgrade its oil production and distribution. His administration has said it expects to sell at least 30 million to 50 million barrels of sanctioned Venezuelan oil.

This story has been corrected to show the Veronica is the fourth, not the third, tanker seized by U.S. forces since Maduro's capture.

U.S. Homeland Security Secretary Kristi Noem speaks during a press conference, Thursday, Jan. 8, 2026, in New York. (AP Photo/Yuki Iwamura)

U.S. Homeland Security Secretary Kristi Noem speaks during a press conference, Thursday, Jan. 8, 2026, in New York. (AP Photo/Yuki Iwamura)

U.S. Homeland Security Secretary Kristi Noem speaks at a news conference at Harry Reid International Airport, Nov. 22, 2025, in Las Vegas. (AP Photo/Ronda Churchill, File)

U.S. Homeland Security Secretary Kristi Noem speaks at a news conference at Harry Reid International Airport, Nov. 22, 2025, in Las Vegas. (AP Photo/Ronda Churchill, File)

Recommended Articles